AlgiPharma AS

AlgiPharma is a biopharmaceutical company with a focus on developing its proprietary alginate technology as a drug delivery platform. AlgiPharma is developing its proprietary alginate technology for: * Delivery platforms for nanoparticles, small and large molecule based drugs. * Drug conjugates, adding functionality and reducing toxicity of parent compound. * Stand alone API in disease areas such as cystic fibrosis, COPD, and infectious diseases. AlgiPharma has pharmaceutical scale production capabilities for its technology protected by a broad family of patents. Our aim is to address unmet medical needs and fight diseases effectively through our innovative alginate technologies. Our alginate technology targets those diseases where there is a clinical need to mitigate abnormal mucus accumulation, non-invasive drug delivery challenges, microbial infection, biofilm formation and antibiotic resistance.